// App-Quantinova.ai

: In patients with treatment-sensitive cancers, does systemic anti-cancer therapy increase the chance of malignant pleural effusion control?

Researchers

Presenter

  • Nina Holling

Principal Investigators

  • Sonia Patole

  • Andrew Medford

  • Nick Maskell

  • Anna Bibby

Medical Centers

  • University Hospitals Bristol NHS Foundation Trust, Wells Somerset, United Kingdom

  • North Bristol NHS Trust, Bristol, United Kingdom

  • University of Bristol, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved